French Biotech Reports Sight Restoration thanks to Gene Therapy – Labiotech.eu (blog)
Business Wire (press release) |
French Biotech Reports Sight Restoration thanks to Gene Therapy
Labiotech.eu (blog) GenSight has announced Phase I/II data revealing that its gene therapy technology can restore sight in patients suffering from a rare mitochondrial disease. GenSight Biologics develops gene therapies targeting degenerative diseases that cause blindness. GenSight Biologics Reports Long-Term Positive Safety and Visual Acuity Results at Week 96 in Phase I/II Study of … |
